Health
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble – The Japan Times
Moderna said it was now expecting sales of between $15 billion and $18 billion from $20 billion estimated previously.
Moderna Inc. on Thursday cut its 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, as it struggles to ramp up production of its two-dose inoculation, sending its shares down nearly 11% in premarket trading.
The company’s sales target…
Continue Reading
-
General17 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News23 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General22 hours agoAustralia welcomes Gaza peace progress, hostage release
-
General14 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell